4//SEC Filing
Flex Pharma, Inc. 4
Accession 0001615219-16-000124
$SLRXCIK 0001615219operating
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:31 PM ET
Size
6.6 KB
Accession
0001615219-16-000124
Insider Transaction Report
Form 4
Wessel Thomas
Chief Medical Officer
Transactions
- Purchase
Common Stock
2016-03-11$7.15/sh+12,000$85,800→ 49,064 total - Purchase
Common Stock
2016-03-14$9.13/sh+8,000$73,040→ 57,064 total
Footnotes (2)
- [F1]The price in Column 4 is a weighted average purchase price. The prices actually received ranged from $6.91 to $7.40. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- [F2]The price in Column 4 is a weighted average purchase price. The prices actually received ranged from $7.69 to $9.58. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
Documents
Issuer
Flex Pharma, Inc.
CIK 0001615219
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001615219
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 4:31 PM ET
- Size
- 6.6 KB